Close Menu

NEW YORK ─ Inflammatix on Thursday announced it has been awarded $7.4 million by the US Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA) to further develop a point-of-care test and system to diagnose infection by reading the immune system.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.